154 related articles for article (PubMed ID: 19908344)
1. CDH1 promoter polymorphism (-347G-->GA) is a possible prognostic factor in sporadic colorectal cancer.
Zou XP; Dai WJ; Cao J
World J Gastroenterol; 2009 Nov; 15(42):5340-5. PubMed ID: 19908344
[TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
[TBL] [Abstract][Full Text] [Related]
3. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
[TBL] [Abstract][Full Text] [Related]
4. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.
Grünhage F; Jungck M; Lamberti C; Berg C; Becker U; Schulte-Witte H; Plassmann D; Rahner N; Aretz S; Friedrichs N; Buettner R; Sauerbruch T; Lammert F
Int J Colorectal Dis; 2008 Feb; 23(2):147-54. PubMed ID: 17960397
[TBL] [Abstract][Full Text] [Related]
5. The E-cadherin -347G->GA promoter polymorphism and its effect on transcriptional regulation.
Shin Y; Kim IJ; Kang HC; Park JH; Park HR; Park HW; Park MA; Lee JS; Yoon KA; Ku JL; Park JG
Carcinogenesis; 2004 Jun; 25(6):895-9. PubMed ID: 14729585
[TBL] [Abstract][Full Text] [Related]
6. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
9. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
10. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
[TBL] [Abstract][Full Text] [Related]
11. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
[TBL] [Abstract][Full Text] [Related]
12. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.
Li W; Xiao D; Wu H; Xu L
Clin Exp Med; 2020 Feb; 20(1):73-78. PubMed ID: 31625007
[TBL] [Abstract][Full Text] [Related]
13. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
[TBL] [Abstract][Full Text] [Related]
14. Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.
Zhao L; Wang YX; Xi M; Liu SL; Zhang P; Luo LL; Liu MZ
Int J Clin Exp Pathol; 2015; 8(5):5753-60. PubMed ID: 26191293
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.
Li HC; Albert JM; Shinohara ET; Cai Q; Freyer A; Cai H; Cao C; Wang Z; Kataoka N; Teng M; Zheng W; Lu B
Urol Oncol; 2006; 24(6):496-502. PubMed ID: 17138130
[TBL] [Abstract][Full Text] [Related]
16. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer.
Chien MH; Chou LS; Chung TT; Lin CH; Chou MY; Weng MS; Yang SF; Chen MK
Head Neck; 2012 Mar; 34(3):405-11. PubMed ID: 21472888
[TBL] [Abstract][Full Text] [Related]
17. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
18. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
[TBL] [Abstract][Full Text] [Related]
20. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
